• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种的价值:依据基于价值的医疗保健方法构建科学证据。

The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.

机构信息

Section of Hygiene, University Department of Life Sciences and Public Health; Catholic University of the Sacred Heart, Rome, Italy.

VIHTALI (Value In Health Technology and Academy for Leadership & Innovation), Spin-Off of Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Front Public Health. 2022 Mar 9;10:786662. doi: 10.3389/fpubh.2022.786662. eCollection 2022.

DOI:10.3389/fpubh.2022.786662
PMID:35359753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8963736/
Abstract

OBJECTIVES

To provide a new value-based immunization approach collating the available scientific evidence on the topic.

METHODS

Four value pillars (personal, allocative, technical, and societal) applied to vaccination field were investigated. A systematic literature review was performed querying three database from December 24th, 2010 to May 27th, 2020. It included studies on vaccine-preventable diseases (VPDs) that mentioned the term value in any part and which were conducted in advanced economies. An in-depth analysis was performed on studies addressing value as key element.

RESULTS

Overall, 107 studies were considered. Approximately half of the studies addressed value as a key element but in most of cases (83.3%) only a single pillar was assessed. Furthermore, the majority of papers addressed the technical value by looking only at classical methods for economic assessment of vaccinations whereas very few dealt with societal and allocative pillars.

CONCLUSIONS

Estimating the vaccinations value is very complex, even though their usefulness is certain. The assessment of the whole value of vaccines and vaccinations is still limited to some domains and should encompass the wider impact on economic growth and societies.

摘要

目的

提供一种新的基于价值的免疫方法,整理该主题的现有科学证据。

方法

研究了适用于疫苗接种领域的四个价值支柱(个人、分配、技术和社会)。从 2010 年 12 月 24 日至 2020 年 5 月 27 日,通过查询三个数据库进行了系统文献回顾。它包括在发达经济体中提到疫苗可预防疾病(VPD)中任何部分的术语价值的研究。对将价值作为关键要素的研究进行了深入分析。

结果

总共考虑了 107 项研究。大约一半的研究将价值作为一个关键要素,但在大多数情况下(83.3%)仅评估了一个支柱。此外,大多数论文通过仅使用评估疫苗接种的经典经济评估方法来研究技术价值,而很少涉及社会和分配支柱。

结论

尽管疫苗的效用是确定的,但评估疫苗接种的价值非常复杂。对疫苗整体价值的评估仍仅限于某些领域,应包括对经济增长和社会的更广泛影响。

相似文献

1
The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.疫苗接种的价值:依据基于价值的医疗保健方法构建科学证据。
Front Public Health. 2022 Mar 9;10:786662. doi: 10.3389/fpubh.2022.786662. eCollection 2022.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.

引用本文的文献

1
[Not Available].[无可用内容]。
J Prev Med Hyg. 2025 Apr 15;66(1 Suppl 2):E1-E56. doi: 10.15167/2421-4248/jpmh2025.66.1s2. eCollection 2025 Apr.
2
Addressing the Underestimated Burden of RSV in Older Adults in Europe: Epidemiology, Surveillance Gaps, and Public Health Implications.应对欧洲老年人中被低估的呼吸道合胞病毒负担:流行病学、监测差距及对公共卫生的影响
Vaccines (Basel). 2025 May 12;13(5):510. doi: 10.3390/vaccines13050510.
3
The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in Italy.佐剂呼吸道合胞病毒预融合F蛋白疫苗对意大利老年人的潜在公共卫生影响
Vaccines (Basel). 2025 Feb 20;13(3):212. doi: 10.3390/vaccines13030212.
4
Healthcare Resource Utilization and Economic Outcomes of RSV-Hospitalized Patients Aged ≥ 60 Years: A Retrospective Cohort Study.≥60岁呼吸道合胞病毒住院患者的医疗资源利用及经济结果:一项回顾性队列研究
Diseases. 2025 Feb 21;13(3):68. doi: 10.3390/diseases13030068.
5
Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort study.意大利呼吸道合胞病毒住院老年人的人口统计学和疾病临床负担:一项回顾性队列研究。
Hum Vaccin Immunother. 2025 Dec;21(1):2479334. doi: 10.1080/21645515.2025.2479334. Epub 2025 Mar 24.
6
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.弱势群体中疫苗安全性和有效性的生物标志物:第四届国际精准疫苗会议的经验教训
Vaccine. 2025 Jan 1;43(Pt 2):126477. doi: 10.1016/j.vaccine.2024.126477. Epub 2024 Nov 28.
7
[Not Available].[无可用内容]
J Prev Med Hyg. 2024 Jun 30;65(2 Suppl 1):E1-E159. doi: 10.15167/2421-4248/jpmh2024.65.2s1. eCollection 2024 Sep.
8
Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy.性传播感染和 HPV 相关负担:意大利流行病学和政策的演变。
Front Public Health. 2024 Mar 15;12:1336250. doi: 10.3389/fpubh.2024.1336250. eCollection 2024.
9
The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy.细胞基四价流感疫苗在意大利用于预防季节性流感的医护人员中的增量使用的经济和财政影响。
Health Res Policy Syst. 2024 Mar 22;22(1):36. doi: 10.1186/s12961-024-01122-w.
10
Influenza vaccination from the perspective of health care workers at university hospitals.从高校医院医护人员的角度看流感疫苗接种。
PLoS One. 2023 Jul 21;18(7):e0288470. doi: 10.1371/journal.pone.0288470. eCollection 2023.

本文引用的文献

1
Recommendations to drive a value-based decision-making on vaccination.关于推动疫苗接种决策的价值导向的建议。
Expert Rev Vaccines. 2022 Mar;21(3):289-296. doi: 10.1080/14760584.2022.2021880. Epub 2022 Jan 4.
2
High overall confidence in childhood vaccination in Norway, slightly lower among the unemployed and those with a lower level of education.挪威民众对儿童疫苗接种的总体信心较高,但在失业人群和受教育程度较低的人群中,信心水平略低。
Vaccine. 2020 Jun 15;38(29):4536-4541. doi: 10.1016/j.vaccine.2020.05.011. Epub 2020 May 21.
3
Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service.流感疫苗接种选择退出是否可行?来自英国国家医疗服务体系疫苗接种项目实施者和管理者的证据。
Vaccine. 2020 May 27;38(26):4183-4190. doi: 10.1016/j.vaccine.2020.04.026. Epub 2020 May 4.
4
Addressing personal parental values in decisions about childhood vaccination: Measure development.解决儿童疫苗接种决策中的个人育儿价值观问题:测量方法的制定。
Vaccine. 2019 Sep 10;37(38):5688-5697. doi: 10.1016/j.vaccine.2019.08.009. Epub 2019 Aug 14.
5
Sense & sensibility: Decision-making and sources of information in mothers who decline HPV vaccination of their adolescent daughters.理智与情感:拒绝为青春期女儿接种人乳头瘤病毒疫苗的母亲的决策与信息来源
Vaccine X. 2019 Apr 4;2:100020. doi: 10.1016/j.jvacx.2019.100020. eCollection 2019 Aug 9.
6
Antimicrobial resistance and the role of vaccines.抗菌药物耐药性与疫苗的作用。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12868-12871. doi: 10.1073/pnas.1717157115.
7
Cost-effectiveness of adult vaccinations: A systematic review.成人疫苗接种的成本效益:系统评价。
Vaccine. 2019 Jan 7;37(2):226-234. doi: 10.1016/j.vaccine.2018.11.056. Epub 2018 Dec 4.
8
The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists.疫苗接种预测和基于价值的支付对社区药剂师成人免疫接种的影响。
Vaccine. 2019 Jan 3;37(1):152-159. doi: 10.1016/j.vaccine.2018.11.018. Epub 2018 Nov 13.
9
Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks.疫苗接种的成本效益分析:八种评估死亡率和发病率风险变化的方法比较分析。
BMC Med. 2018 Sep 5;16(1):139. doi: 10.1186/s12916-018-1130-7.
10
Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan.日本孕期百日咳疫苗接种的成本效益分析。
Vaccine. 2018 Aug 16;36(34):5133-5140. doi: 10.1016/j.vaccine.2018.07.026. Epub 2018 Jul 21.